Treatment in Patients With Globus: Psychoeducation, Anxiolytics or Proton Pump Inhibitors
NCT03205228 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2018-08-22
Summary
A randomized controlled trial study is conducted to compare treatment efficacy between psycho-education, anxiolytics drug and proton pump inhibitors in participants who met the criteria of globus.
Conditions
- Globus
Interventions
- DRUG
-
Omeprazole
A capsule of Omeprazole 20 mg \& 1 capsule of placebo will be given in individual subject, once daily for 4 weeks. Both drugs will be presented in the same appearance (white capsule).
- BEHAVIORAL
-
psychoeducation
Psychoeducation will be given by psychologists at the Day 1 and Day 15 of the study period.One white capsule of placebo will be given once daily for 4 weeks of the study period.
- DRUG
-
Flupentixol +Melitracen
A capsule containing of a tablet of melitracen 10 mg + flupentixol 0.5 mg \& a capsule of placebo will be given once daily, for 4 weeks. Both would be presented in the same appearance (white capsule)
Sponsors & Collaborators
-
Mahidol University
lead OTHER
Principal Investigators
-
Monthira Maneerattanaporn, MD., MS. · Mahidol University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-07-07
- Primary Completion
- 2018-06-26
- Completion
- 2018-07-28
Countries
- Thailand
Study Locations
More Related Trials
-
Impact of Glossopharyngeal Nerve Block on Swallowing Difficulties Caused by Gastroesophageal Reflux Disease
NCT06328205 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD)
NCT01472939 ·Status: COMPLETED ·Phase: PHASE2
-
A Randomized Trial of Medical and Surgical Treatments for Patients With GERD Symptoms That Are Refractory to Proton Pump Inhibitors
NCT01265550 ·Status: COMPLETED ·Phase: PHASE3
-
The Mechanism Versus PPI Trial
NCT06999577 ·Status: RECRUITING ·Phase: PHASE4
-
A Novel Endoloop Pre-test to Treat Gastroesophageal Reflux
NCT05192538 ·Status: UNKNOWN ·Phase: NA
-
Comparison of Voice Therapy and Antireflex Therapy in LPR
NCT02530879 ·Status: WITHDRAWN ·Phase: PHASE4
-
In Infants With Laryngomalacia, Does Acid-Blocking Medication Improve Respiratory Symptoms?
NCT02700087 ·Status: WITHDRAWN ·Phase: NA
-
Long Term Outcome of Argon Plasma Coagulation of Cervical Heterotopic Gastric Mucosa as an Alternative Treatment for Globus Sensations
NCT01574755 ·Status: COMPLETED
-
The Effect of Proton Pump Inhibition on Palpitations
NCT03273634 ·Status: COMPLETED ·Phase: PHASE4
-
Radiofrequency Ablation vs Sham Procedure for Symptomatic Cervical Inlet Patch
NCT03471052 ·Status: UNKNOWN ·Phase: NA
-
A Study to Evaluate the Safety, Tolerability and Pharmacodynamics of Pumosetrag in Patients With Gastroesophageal Reflux Disease (GERD)
NCT01161602 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Glossopharyngeal Nerve Block on Pharyngeal Dysphagia Induced by Gastroesophageal Reflux Disease
NCT06215794 ·Status: WITHDRAWN ·Phase: NA
-
Fosamprenavir for Laryngopharyngeal Upper Airway Tissue Treatment and Enzyme Reduction
NCT04383262 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Longitudinal Study of Children With a Chronic Cough and the Impact of Gastroesophageal Reflux
NCT00771706 ·Status: WITHDRAWN ·Phase: PHASE3
-
Evaluating Medication Adherence of Patients With Gastroesophageal Reflux Disease With Support of Smartphone Application GERDCare
NCT07127276 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Impact of Blocking the Glossopharyngeal Nerve on Gastroesophageal Reflux Disease
NCT06304870 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Stellate Ganglion Block on Gastroesophageal Reflux Disease
NCT06319521 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Validation of Patient-reported Outcomes Measures for the Assessment of Gastroesophageal Reflux Disease (GERD) Symptoms
NCT00703534 ·Status: COMPLETED ·Phase: PHASE2
-
The Influence of Hypnotic Medications on Sleep Arousal and Its Effect on Gastroesophageal Reflux
NCT00462137 ·Status: COMPLETED
-
Effects of AFQ056 and Baclofen on Meal-Induced Gastroesophageal Reflux
NCT00414856 ·Status: COMPLETED ·Phase: PHASE1
-
ACHAT-STUDY, Alternative Treatment of Chronic Globus Sensations
NCT00439439 ·Status: COMPLETED ·Phase: NA
-
Evaluating Medication Adherence of Patients With Gastroesophageal Reflux Disease With Support of the Smartphone Application GERDCare
NCT07125521 ·Status: RECRUITING ·Phase: NA
-
Antireflux Ablation of the Cardia Mucosa vs Placebo for the Treatment of Gastroesophageal Reflux Disease
NCT04711655 ·Status: COMPLETED ·Phase: NA
-
Cognitive-behavioral Therapy for the Diseases Associated With Esophageal-brain-gut Axis Communication Abnormalities.
NCT06939465 ·Status: RECRUITING ·Phase: NA
-
Treatment Of Gastroesophageal Reflux Disease By Endoscopic Fundoplication, A Placebo-Controlled Study
NCT00235677 ·Status: COMPLETED ·Phase: PHASE3